Pressure Ulcers Stage III Clinical Trial
Official title:
Effectiveness of Negative-Pressure Wound Therapy Compared to Wet-Dry Dressing in Pressure Injuries
This study aims to compare the effects of Negative-Pressure Wound Therapy and wet-to-dry dressing on Stages 3 and 4 pressure injuries, and to investigate the consistency of Three-Dimensional Wound Measurement Device findings with Pressure Ulcer Scale for Healing Tool scores. This study is a randomized controlled trial. A total of 30 patients with Stages 3 and 4 pressure injuries were included in the study. The patients were divided into two groups: the experimental group or Negative-Pressure Wound Therapy group and the control or wet-to-dry dressing group. All patients received 3 rounds of treatment. Data were collected with a Patient Identification Form, Pressure Ulcer Scale for Healing Tool and the findings of Three-Dimensional Wound Measurement Device. We found that granulation tissue formation was more significant in the experimental group (p < .05), and that there was more significant wound shrinkage (p < .05) with a more significant decrease in the Pressure Ulcer Scale for Healing Tool scores (p < .05). The wounds were assessed with the Tool and the Three-Dimensional Wound Measurement device. Device measurements were found to be correlated with Pressure Ulcer Scale for Healing Tool Tool findings (p < .05) There was a significant correlation between device-measured granulation findings and PUSH Tool score results of the experimental group's third measurements (p < .05). We conclude that Negative-Pressure Wound Therapy is an effective treatment method for pressure injuries, and Three-Dimensional Wound Measurement device is an usable wound assessment tool.
Pressure injuries are a major health problem in that they are difficult to treat, reduce the
patients' quality of life, and increase length of hospital stay and overall health care
costs. Furthermore, several possible wound healing complications, such as infections, can
lead to mortality. That said, the prevalence of pressure injuries is an important indicator
of quality in hospitals. Pressure injuries do not only impact health, but also cause social
isolation and dependency, resulting in further psychological problems.
Our review of the literature revealed that the incidence of pressure ulcers varies between
0.4% and 38% in hospitalized patients, between 2.2 and 23.9% in intensive care units and
between 0-17% in home care. NPUAP (National Pressure Ulcer Advisory Panel) reports that the
cost of treating pressure ulcers has been gradually increasing. It was estimated that
treating pressure injuries costs around $11 billion annually in the United States alone.
Treating a pressure ulcer can cost anywhere between $500 to $70,000, the most substantial
fraction being nursing services. In the UK, it costs £1,064 to treat a Stage 1 pressure
injury, and this number can reach £10,551 for more advanced ulcers. This illustrates the
direct link between the stage of pressure injury and the cost of treatment. On average, it
costs the UK healthcare system £1.4-2.1 billion annually to treat pressure ulcers.
There are many products and methods available for pressure ulcer treatment, but the most
well-known and most commonly preferred method is wet-to-dry dressing. That said, researchers
have tried and developed several novel methods for the treatment of pressure injuries
including NPWT (Negative-Pressure Wound Therapy), hyperbaric oxygen therapy, ultrasonography,
hydrotherapy, magnetic field therapy, ultraviolet rays, electrical stimulation, phototherapy
and growth hormone application. Together with these non-invasive treatment methods, surgical
intervention can also be a treatment option, especially for non-healing wounds. The European
and US National Pressure Ulcer Advisory Panels' (EPUAP and NPUAP) guidelines recommend NPWT
for deep-tissue pressure injuries, namely Stages 3 and 4, as a supportive tool for
early-stage treatment. This method is based on applying negative pressure to promote wound
healing. Several studies report that NPWT increases granulation tissue formation and reduces
wound area. It is indicated that NPWT provides continuous and effective wound debridement in
the wound area and increases blood supply to the wound.
Pressure injuries are among the most significant current health problems that are handled by
a medical nurse. As the primary caregiver for the hospitalized patient, the nurse must
prioritize preventing wound formation and eliminating any risk factors. If a pressure sore
does form, the primary goal is to plan and implement appropriate care and nursing
interventions in collaboration with the patient and their family to ensure proper wound
healing .
It is the nurse's responsibility to keep up with scientific developments in patient care and
try to integrate them into their work. PUSH is a tool that is used for monitoring pressure
ulcers; however, it has yet to become a part of routine practice in Turkey. The
Three-Dimensional Wound Management (3-DWM) device has been used in medical service since
2015, but with only a limited number of studies that evaluate its effectiveness. Currently,
the wet-to-dry dressing method is the most commonly preferred treatment method for wound care
in Turkish healthcare. There are indeed numerous studies that demonstrate the effectiveness
of wet dressings in wound healing. Wet dressings provide the appropriate medium for the
accumulation of patient's own body fluids between wound surface and dressing while preventing
dehydration. This study aims to compare the effects of Negative-Pressure Wound Therapy (NPWT)
and wet-to-dry dressing on Stages 3 and 4 pressure injuries, and to investigate the
consistency of 3-DWM device measurement findings with PUSH Tool scores.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05894291 -
Comparaison of Two Prone Position Techniques on Occurence of Pressure Sores in ICU
|
N/A | |
Completed |
NCT02222454 -
Safety Evaluation of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers
|
N/A | |
Not yet recruiting |
NCT05649332 -
Study to Evaluate the Performance and Safety of the Medical Device Argogen
|
N/A | |
Completed |
NCT05130814 -
EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers
|
N/A | |
Recruiting |
NCT03038490 -
The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for Treatment of Pressure Ulcers
|
N/A | |
Recruiting |
NCT05496296 -
Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries
|
N/A | |
Completed |
NCT03283787 -
Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytalâ„¢ to Standard of Care in Stage 3 or 4 Pressure Injuries
|
N/A |